Adverum Biotechnologies News

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights

Aug 12 16:12 ET

Adverum Biotechnologies | 8-K: Current report

Jul 17 16:42 ET

Adverum Biotechnologies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 28 16:08 ET

Adverum Biotechnologies | 8-K: Current report

Jun 18 16:13 ET

Adverum Biotechnologies | 8-K: Current report

Jun 11 16:26 ET

Adverum Biotechnologies | DEFA14A: Others

Jun 11 16:24 ET

Adverum Biotechnologies | DEFA14A: Others

May 28 14:01 ET

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights

May 9 17:08 ET

Adverum Biotechnologies | DEFA14A: Others

May 2 16:35 ET

Adverum Biotechnologies | DEF 14A: Definitive information statements

May 2 16:31 ET

Adverum Biotechnologies | S-3: Registration statement for specified transactions by certain issuers

Mar 21 17:27 ET

Adverum Biotechnologies | 8-K: Current report

Mar 20 16:19 ET

Adverum Biotechnologies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 18 17:01 ET

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates

Mar 18 16:12 ET

Adverum Biotechnologies | S-3: Registration statement for specified transactions by certain issuers

Mar 4 16:41 ET

Adverum Biotechnologies | 8-K: Current report

Feb 8 08:50 ET

Adverum Biotechnologies | 8-K: Current report

Feb 6 16:48 ET

Adverum Biotechnologies | 8-K: Current report

Feb 5 17:10 ET

Adverum Biotechnologies | 8-K: Current report

Dec 8, 2023 16:11 ET

Adverum Biotechnologies | 8-K/A: Current report (Amendment)

Dec 4, 2023 16:09 ET